This PDF is the current document as it appeared on Public Inspection on 02/11/2013 at 08:45 am.
Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Arthritis and Musculoskeletal and Skin Diseases Special Emphasis Panel; Ancillary Studies To Large Clinical Projects Grant Review.
Date: March 1, 2013.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health,, Suite 818, 6706 Democracy Blvd., Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Charles N. Rafferty, Ph.D., Chief, Scientific Review Branch, 6701 Democracy Boulevard, Suite 800, National Institute of Arthritis, Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20817, 301-594-5019, firstname.lastname@example.org.
(Catalogue of Federal Domestic Assistance Program Nos. 93.846, Arthritis, Musculoskeletal and Skin Diseases Research, National Institutes of Health, HHS)Start Signature
Dated: February 5, 2013.
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-03113 Filed 2-11-13; 8:45 am]
BILLING CODE 4140-01-P